Current Antimicrobial Susceptibility Trends and Clinical Outcomes of Typhoidal Salmonella in a Large Health Authority in British Columbia, Canada
Currently, in British Columbia, MDR typhoidal <i>Salmonella</i> remains rare. Empiric ciprofloxacin should be avoided due to persistently high resistance rates. With ongoing travel patterns, it is beneficial for institutions to continue typhoidal <i>Salmonella</i> antimicrobial susceptibility surveillance, and travelers should seek pre-travel health assessments.
Authors
- Shazia Masud (ORCID: https://orcid.org/0000-0001-9396-050X)
- Mac Mok (ORCID: https://orcid.org/0000-0003-1726-753X)
- Calvin Ka-Fung Lo (ORCID: https://orcid.org/0000-0003-3664-736X)
- Cole Schonhofer (ORCID: https://orcid.org/0000-0002-5226-5137)
- Kevin Afra (ORCID: https://orcid.org/0009-0000-9900-4674)
Institutions
- University of British Columbia (CA)
- Fraser Health (CA)
- Surrey Memorial Hospital (CA)
Publication Details
- Journal
- Tropical Medicine and Infectious Disease
- Published
- 2025-04-15
- DOI
- https://doi.org/10.3390/tropicalmed10040108
- Primary Topic
- Salmonella and Campylobacter epidemiology
- Type
- article
- Field-Weighted Citation Impact
- 0.00